Clinical Trial Update: HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

View source ↗

Summary

Brazilian clinical trial update examining HIV drug resistance in individuals failing a first-line regimen of tenofovir disoproxil fumarate/lamivudine with dolut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Epivir (Lamivudine)
• Tivicay (dolutegravir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Federal University of São Paulo | Conditions: HIV, Drug | Status: ACTIVE_NOT_RECRUITING